This paper summarizes the latest progress in the elimination of hepatitis B worldwide and in China.Although the global burden of hepatitis B is decreasing,there is a large difference in the progress towards elimination across different countries,and among the 20 countries with the heaviest disease burden,Bangladesh,India,Indonesia,Japan,and Russia have achieved substantial progress.China continues to maintain a high HBV vaccination coverage for neonates,with an inoculation rate of 95.6%for timely birth dose and 99.6%for 3 doses.From 2016 to 2022,the diagnosis rate of patients with chronic hepatitis B in China have increased from 19%to 24%,and treatment rate have increased from 11%to 15%;however,there is still a big gap compared with the WHO targets by 2030.Further efforts are needed to eliminate viral hepatitis by 2030 globally and in China.
Hepatitis B,ChronicDiagnosisTherapeuticsPublic Health
国家科技期刊平台
NSTL
万方数据
